Paliperidone for schizophrenia in Bangladesh
Part of Mental health clinical trials.
This study tests a medication called paliperidone for treating schizophrenia. It aims to see how well it works and how safe it is for people in Bangladesh, comparing it to the standard of care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have a schizophrenia diagnosis that was made at least 3 months ago.
- You have either never taken antipsychotic medicine, or you have tried one and it didn't help enough or caused bad side effects.
- You have been feeling stable for at least 2 weeks before starting the study.
- You have not used long-acting (depot) antipsychotic injections in the last 3 months.
- You are not pregnant or breastfeeding, and you don't have serious medical or brain conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new version of an extended-release injection is as effective as the original in people with schizophrenia. The study helps ensure patients have access to a reliable treatment option.
This study tests an extended-release form of the medication brexpiprazole, given as an injection, for people with schizophrenia. It aims to see how the drug moves through the body and how safe it is.
This trial tests a new medication called LB-102 for people with acute (sudden worsening of) schizophrenia. It aims to see if the drug helps reduce symptoms like hallucinations or disorganized thinking.
This study looks at whether people with schizophrenia who are currently stable on oral antipsychotics can switch back to daily pills from a long-acting injection (paliperidone palmitate). The goal is to see if symptoms stay controlled and daily functioning improves after the switch.
This study looks at long-acting (extended-release) antipsychotic medicine options in people with schizophrenia, compared with regular tablets. You may be able to join if you were already part of a related earlier study or its real-world follow-up.
This trial tests a monthly injection of cariprazine (a medication for mental health conditions) in people who could benefit from it. It aims to see if the shot is safe, tolerable, and effective compared to taking pills every day.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.